|
[Related PubMed/MEDLINE]
Total Number of Papers: 578
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: PC |
| Long Form |
: peritoneal carcinomatosis |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
A precise temperature control during hyperthermic intraperitoneal chemotherapy promises an early return of bowel function. |
HIPEC, OS, VAS |
| 2 |
2020 |
Clinical outcomes of curative treatment for colorectal liver metastases combined with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases: a systematic review and meta-analysis of current evidence. |
CI, CRC, HRs, LM, RRs |
| 3 |
2020 |
Clinicopathological and Molecular Study of Peritoneal Carcinomatosis Associated with Non-Small Cell Lung Carcinoma. |
NGS, NSCLC |
| 4 |
2020 |
Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer. |
CRC, CRS, HIPEC, MMC, PCI |
| 5 |
2020 |
Comparison of the outcomes of cytoreductive surgery versus surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: a propensity score matching analysis. |
CRS, HIPEC, PSM |
| 6 |
2020 |
Current Opinion on Peritoneal Carcinomatosis Treatment: a Survey of the Indian Society of Peritoneal Surface Malignancies (ISPSM). |
HIPEC, ISPSM |
| 7 |
2020 |
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis. |
CRS, HIPEC, PCI |
| 8 |
2020 |
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer: The prognostic impact of baseline neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios. |
CC, CRC, CRS-HIPEC, LMR, NLR, OS, PCI, PLR |
| 9 |
2020 |
Diagnostic performance of CT for differentiating peritoneal tuberculosis from peritoneal carcinomatosis: a systematic review and meta-analysis. |
AUC, PTB, SROC |
| 10 |
2020 |
Dietary fats suppress the peritoneal seeding of colorectal cancer cells through the TLR4/Cxcl10 axis in adipose tissue macrophages. |
ATMs, CRC, HFD |
| 11 |
2020 |
Distal pancreatectomy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Identifying risk and improving patient selection. |
CRS/HIPEC, DP |
| 12 |
2020 |
Efficacy of ascitic fluid cell block for diagnosing primary ovarian, peritoneal, and tubal cancer in patients with peritoneal carcinomatosis with ascites. |
ACB, CNB |
| 13 |
2020 |
Endoscopic Ultrasound-Guided Random Omental Fine Needle Aspiration: A Novel Technique for the Diagnosis of Peritoneal Carcinomatosis. |
EUS, EUS-FNA |
| 14 |
2020 |
Evaluation of a Novel Prototype for Pressurized Intraperitoneal Aerosol Chemotherapy. |
DCD, DMD, PIPAC |
| 15 |
2020 |
Functional tumour burden of peritoneal carcinomatosis derived from DWI could predict incomplete tumour debulking in advanced ovarian carcinoma. |
ADC, fPCI, OC, sPCI |
| 16 |
2020 |
Gastric Cancer Peritoneal Carcinomatosis Risk Score. |
CI, GC, IQR, OR |
| 17 |
2020 |
High-grade complication is associated with poor overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. |
CRS, HIPEC |
| 18 |
2020 |
Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy. |
CRS, HIPEC |
| 19 |
2020 |
Impact of Perfusate Concentration on Hyperthermic Intraperitoneal Chemotherapy Efficacy and Toxicity in a Rodent Model. |
CRC, HIPEC |
| 20 |
2020 |
Improved Survival with Experience: A 10-Year Learning Curve in Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery. |
CRS/HIPEC, EBL, ICU, LOS, PCI |
| 21 |
2020 |
In vivo Spectroscopic Evaluation of the Intraperitoneal Cavity in Canines. |
BPD, PDT |
| 22 |
2020 |
Influence of peritoneal carcinomatosis on perioperative outcome in palliative gastric bypass for malignant gastric outlet obstruction - a retrospective cohort study. |
GJJ, GOO |
| 23 |
2020 |
Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center. |
HIPEC, PIPAC |
| 24 |
2020 |
Intraperitoneal CMP-001: A Novel Immunotherapy for Treating Peritoneal Carcinomatosis of Gastrointestinal and Pancreaticobiliary Cancer. |
ELISA, IFN-alpha, IL-6, NK, pDCs |
| 25 |
2020 |
Iodine overlays to improve differentiation between peritoneal carcinomatosis and benign peritoneal lesions. |
AUC, BPA, CI, IO, SDCT |
| 26 |
2020 |
Is ascites CEA a risk factor for peritoneal carcinomatosis in colorectal cancer?: a long-term follow-up study. |
CEA, CRC |
| 27 |
2020 |
Locoregional peritoneal hyperthermia to enhance the effectiveness of chemotherapy in patients with peritoneal carcinomatosis: a simulation study comparing different locoregional heating systems. |
HIPEC, SAR, TER |
| 28 |
2020 |
Management of Peritoneal Carcinomatosis With Cytoreductive Surgery Combined With Intraperitoneal Chemohyperthermia at a Novel Italian Center. |
CRS, GI, HIPEC, PM, QOL |
| 29 |
2020 |
Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. |
GAC, Tim-3, VISTA, WES |
| 30 |
2020 |
N-Acetyl-l-cysteine Enhances the Effect of Selenium Nanoparticles on Cancer Cytotoxicity by Increasing the Production of Selenium-Induced Reactive Oxygen Species. |
NAC, ROS, SeNPs |
| 31 |
2020 |
Novel Chimeric Immuno-Oncolytic Virus CF33-hNIS-antiPDL1 for the Treatment of Pancreatic Cancer. |
hNIS, i.p, MOI, PDAC, s.c |
| 32 |
2020 |
Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC). |
CRS/HIPEC, GCA |
| 33 |
2020 |
Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters. |
BD, CPLN, CT, OC |
| 34 |
2020 |
Palliative treatment for malignant gastrointestinal obstruction with peritoneal carcinomatosis: enteral stenting versus surgery. |
AEs, ECOG, MGIO |
| 35 |
2020 |
Peritoneal Carcinomatosis and Its Mimics: Review of CT Findings for Differential Diagnosis. |
CT |
| 36 |
2020 |
Peritoneal carcinomatosis in gastric cancer: Are Hispanics at higher risk? |
NHB, NHW |
| 37 |
2020 |
Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options. |
GEP-NENs, PRRT |
| 38 |
2020 |
Peritoneal Cell-Free Tumor DNA as Biomarker for Peritoneal Surface Malignancies. |
CRS, ddPCR, MAF |
| 39 |
2020 |
Preclinical Evaluation of Cetuximab and Benzoporphyrin Derivative-Mediated Intraperitoneal Photodynamic Therapy in a Canine Model. |
BPD, EGFR, PDT, SBR |
| 40 |
2020 |
Primary Peritoneal High-grade Serous Carcinoma Misinterpreted as Metastatic Breast Carcinoma: A Rare Encounter in Peritoneal Fluid Cytology. |
HGSC, PAX8, PF, WT1 |
| 41 |
2020 |
Prognostic Value and Risk Factors of Peritoneal Carcinomatosis Recurrence for Patients with Endometrial Cancer: A Multicenter Study from the FRANCOGYN Group. |
EC, FIGO, OS, OSAR, PCR |
| 42 |
2020 |
Prophylactic HIPEC in pT4 Colon Tumors: Proactive Approach or Overtreatment? |
HIPEC |
| 43 |
2020 |
Role of hyperthermic intraperitoneal chemotherapy in ovarian cancer. |
CRS, CT, DFS, EOC, HIPEC, OS |
| 44 |
2020 |
ROS1-rearranged lung adenocarcinoma with peritoneal carcinomatosis on initial presentation. |
ROS1 |
| 45 |
2020 |
Strategies for 'bloodless' surgery: the experience of cytoreductive surgery for peritoneal carcinomatosis in Jehovah's Witnesses. |
CRS, HIPEC |
| 46 |
2020 |
Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial. |
AC, AGC, HIPEC, NAC, NLHIPEC, NLHIPEC, OS, PFS, PMR, WHO-ICTRP |
| 47 |
2020 |
Synergy between Intraperitoneal Aerosolization (PIPAC) and Cancer Nanomedicine: Cisplatin-Loaded Polyarginine-Hyaluronic Acid Nanocarriers Efficiently Eradicate Peritoneal Metastasis of Advanced Human Ovarian Cancer. |
Cis-pARG-HA NPs, PIPAC |
| 48 |
2020 |
The importance of primary tumor origin in gastrointestinal malignancies undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. |
CRS/HIPEC, PCI |
| 49 |
2020 |
The Safety of Iterative Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis: A High Volume Center Prospectively Maintained Database Analysis. |
CRS/HIPEC |
| 50 |
2020 |
YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition. |
CSC, GAC, PDO, PDX, RNA-Seq, scRNA-Seq, YAP1 |
| 51 |
2019 |
Aerosolization of Nanotherapeutics as a Newly Emerging Treatment Regimen for Peritoneal Carcinomatosis. |
i.p, PIPAC |
| 52 |
2019 |
Alteration of Adaptive Immunity in a Colorectal Peritoneal Carcinomatosis Model. |
CRC |
| 53 |
2019 |
Analysis of Bacterial and Fungal Infections after Cytoreduction Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Observational Single-Centre Study. |
APTT, CI, CRS, ESBL, HIPEC, HR |
| 54 |
2019 |
Calculation of a clinical predictive factors identifying peritoneal disease on a staging laparoscopy in gastric cancers. |
GCs, SL |
| 55 |
2019 |
Cost-Effectiveness Analysis of Cytoreductive Surgery and HIPEC Compared With Systemic Chemotherapy in Isolated Peritoneal Carcinomatosis From Metastatic Colorectal Cancer. |
CRS, HIPEC, ICER, LYs, mCRC, PSA, QALYs, WTP |
| 56 |
2019 |
Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study. |
CC0, CRC, CRS-HIPEC, DFS, HR, IQR, OS, PCI |
| 57 |
2019 |
Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis from rare etiologies. |
CRS/HIPEC, OS |
| 58 |
2019 |
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP). |
CI, CRS, DFS, GC, GECOP, HIPEC, HR, OS, PCI |
| 59 |
2019 |
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a patient with peritoneal carcinomatosis from a pancreatic cystadenocarcinoma: A case report. |
CRS, CT, HIPEC |
| 60 |
2019 |
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: morbidity and postoperative outcomes. |
CRS, HIPEC |
| 61 |
2019 |
Different Features of Tumor-Associated NK Cells in Patients With Low-Grade or High-Grade Peritoneal Carcinomatosis. |
CRS/HIPEC, PF |
| 62 |
2019 |
Differentiation of peritoneal tuberculosis from peritoneal carcinomatosis by the Omental Rim sign. A new sign on contrast enhanced multidetector computed tomography. |
CT, CT-OR, PTB |
| 63 |
2019 |
Diffusion-weighted magnetic resonance imaging in peritoneal carcinomatosis from suspected ovarian cancer: Diagnostic performance in correlation with surgical findings. |
CT, DP, DWI-MRI, OC, PCI |
| 64 |
2019 |
Early postoperative intraperitoneal chemotherapy for lower gastrointestinal neoplasms with peritoneal metastasis: a systematic review and critical analysis. |
CRS, EPIC, HIPEC |
| 65 |
2019 |
Efficacy of postoperative intraperitoneal hyperthermic perfusion chemotherapy with oxaliplatin + 5-Fluorouracil in the treatment of gastric cancer patients with peritoneal carcinomatosis. |
5-FU, BUN, IHPC, KPS, SCr |
| 66 |
2019 |
Evaluation of Enhanced Recovery After Following a Surgical Protocol for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis. |
ERAS |
| 67 |
2019 |
Exploring the Use of Pegylated Liposomal Doxorubicin (Caelyx) as Pressurized Intraperitoneal Aerosol Chemotherapy. |
PIPAC, PLD |
| 68 |
2019 |
Extended abdominopelvic MRI versus CT at the time of adnexal mass characterization for assessing radiologic peritoneal cancer index (PCI) prior to cytoreductive surgery. |
PCI |
| 69 |
2019 |
Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies using new hybrid CO2 system: preliminary experience in referral center. |
HIPEC |
| 70 |
2019 |
Incidence and risk factors for peritoneal carcinomatosis following open radical cystectomy. |
CSS, IQR, OSS, RC |
| 71 |
2019 |
More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. |
CRC, CRS/HIPEC |
| 72 |
2019 |
Overall clinical and trichoscopic analysis performed in patients who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis - initial trial preliminary report. |
PIPAC |
| 73 |
2019 |
Peritoneal Carcinomatosis Diagnosis and Treatment in China: Focusing on Training and Collaboration. |
CRS, HIPEC |
| 74 |
2019 |
Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review. |
NSCLC, OS |
| 75 |
2019 |
Peritoneal Carcinomatosis in Well-Differentiated Small-Intestinal Neuroendocrine Tumors with Mesenteric Tumor Deposits. |
MTDs, SI-NETs |
| 76 |
2019 |
Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study. |
CRS, DFS, HIPEC, PCI |
| 77 |
2019 |
Preoperative assessment of splenic involvement in patients with peritoneal carcinomatosis with CT and MR imaging. |
CRS, CT, HIPEC, MRI |
| 78 |
2019 |
Pressurized intraperitoneal aerosol chemotherapy procedure for nonresectable peritoneal carcinomatosis: First Indian study. |
PIPAC |
| 79 |
2019 |
Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept. |
i.p, PCI, PRIT, TCO, Tz |
| 80 |
2019 |
Prevention of Venous Thromboembolism After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Development of a Physiotherapy Program. |
CRS, HIPEC, VTE |
| 81 |
2019 |
Short-term complications in elderly patients undergoing CRS and HIPEC: A single center's initial experience. |
CRC, CRS, HIPEC, PCI, PMP, SAE |
| 82 |
2019 |
Signet ring cell features with peritoneal carcinomatosis in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are associated with poor overall survival. |
AC, CRC, CRS/HIPEC, GC, PCI, SRC |
| 83 |
2019 |
Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience. |
AC, CI, CRC, DFS, HIPEC |
| 84 |
2019 |
Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. |
CRC, CRS, HIPEC |
| 85 |
2019 |
Synchronous pancreas and liver resection during CRS HIPEC. Results of 35 consecutive patients. |
CRS, CT, HIPEC |
| 86 |
2019 |
The Current Status of Peritoneal Surface Oncology in Saudi Arabia. |
CRS, HIPEC |
| 87 |
2019 |
The impact of BMI extremes on disease-free survival and overall survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. |
BMI, CRS, DFS, HIPEC, OS, PMP |
| 88 |
2019 |
Tumor-sealing Surgical Orthotopic Implantation of Human Colon Cancer in Nude Mice Induces Clinically-relevant Metastases Without Early Peritoneal Carcinomatosis. |
GFP, SSI, TSM |
| 89 |
2019 |
Use of hyperthermia versus normothermia during intraperitoneal chemoperfusion with oxaliplatin for colorectal peritoneal carcinomatosis: A propensity score matched analysis. |
CCI, CD, HIPEC, OX, PS |
| 90 |
2019 |
Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases. |
CT, DWI, MRI, NPV, PCI, PPV |
| 91 |
2019 |
[Factors affecting the survival of patients with peritoneal carcinomatosis of colorectal origin]. |
CRC, CS, DFS, HIPEC, PCI |
| 92 |
2019 |
[Prevention of carcinomatosis in colon cancer]. |
CRC |
| 93 |
2018 |
Analysis of patient selection policy and pattern of recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal carcinomatosis. |
CRS, HIPEC |
| 94 |
2018 |
Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma. |
MBC, PF, PPOC |
| 95 |
2018 |
Comparison of Survival in Patients with Isolated Peritoneal Carcinomatosis from Colorectal Cancer Treated with Cytoreduction and Melphalan or Mitomycin-C as Hyperthermic Intraperitoneal Chemotherapy Agent. |
CRC, HIPEC, OS, PCI, PFS |
| 96 |
2018 |
Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis. |
PIPAC |
| 97 |
2018 |
Could texture features from preoperative CT image be used for predicting occult peritoneal carcinomatosis in patients with advanced gastric cancer? |
AGC, ROC, ROI |
| 98 |
2018 |
Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy for Management of Peritoneal Carcinomatosis. |
CRS, HIPEC, OS |
| 99 |
2018 |
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: results from a 7-year experience. |
AC, CRC, CRS, CTCAE, DFS, GC, HIPEC, OC, OS |
| 100 |
2018 |
Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis. |
CRS, GC, HIPEC, OS |
|
A Search Service for Abbreviation / Long Form
